The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 3, 2014, Pages 562-571

  Kasiske, Bertram L ^a,b   Stewart, Darren E ^b   Bista, Bipin R ^c   Salkowski, Nicholas ^a   Snyder, Jon J ^a,d   Israni, Ajay K ^a,b,d   Crary, Gretchen S ^d   Rosendale, John D ^b   Matas, Arthur J ^e   Delmonico, Francis L ^f  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNITED NETWORK FOR ORGAN SHARING   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f New England Organ Bank   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ARTICLE; ATROPHY; CASE CONTROL STUDY; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; GRAFT FAILURE; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PROCUREMENT BIOPSY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SYSTEMIC HYALINOSIS; TREATMENT OUTCOME;

BIOPSY; DONOR SELECTION; GRAFT SURVIVAL; HEALTH SERVICES ACCESSIBILITY; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84896844672     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07610713     Document Type: Article

References (47)

1. Matas AJ, Smith JM, Skeans MA, Lamb KE, Gustafson SK, Samana CJ, Stewart DE, Snyder JJ, Israni AK, Kasiske BL: OPTN/SRTR 2011 Annual Data Report: Kidney. Am J Transplant 13[Suppl 1]: 11-46, 2013.
2. Hopfer H, Kemény E: Assessment of donor biopsies. Curr Opin Organ Transplant 18: 306-312, 2013.
3. Rao PS, Schaubel DE, Guidinger MK, Andreoni KA, Wolfe RA, Merion RM, Port FK, Sung RS: A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk index. Transplantation 88: 231-236, 2009.
4. Leppke S, Leighton T, Zaun D, Chen SC, Skeans M, Israni AK, Snyder JJ, Kasiske BL: Scientific Registry of Transplant Recipients: Collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev (Orlando) 27: 50-56, 2013.
5. Hollander M, Wolfe DA: Nonparametric Statistical Methods, 2nd Ed., New York, John Wiley & Sons, 1999.
6. Datta S, Satten GA: A signed-rank test for clustered data. Biometrics 64: 501-507, 2008.
7. Inker LA, Eckfeldt J, Levey AS, Leiendecker-Foster C, Rynders G, Manzi J, Waheed S, Coresh J: Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 58: 682-684, 2011.
8. Leunissen KM, Bosman FT, Nieman FH, KootstraG, Vromen MA, Noordzij TC, van Hooff JP: Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney. Transplantation 48: 590-593, 1989.
9. Taub HC, Greenstein SM, Lerner SE, Schechner R, Tellis VA: Reassessment of the value of post-vascularization biopsy performed at renal transplantation: The effects of arteriosclerosis. J Urol 151: 575-577, 1994.
10. Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO: Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 60: 334-339, 1995.
11. Minakawa R, Tydén G, Lindholm B, Reinholt FP: Donor kidney vasculopathy: Impact on outcome in kidney transplantation. Transpl Immunol 4: 309-312, 1996.
12. Szánya J, Szakály P, Magyarlaki T, Balogh Z, Nagy J, Nagy KK: Predictive morphological findings in "zero-hour" biopsies of renal allografts. Acta Chir Hung 36: 346-348, 1997.
13. Wang HJ, Kjellstrand CM, Cockfield SM, Solez K: On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. Nephrol Dial Transplant 13: 165-172, 1998.
14. Cosyns JP, Malaise J, Hanique G, Mourad M, Baldi A, Goebbels RM, Squifflet JP: Lesions in donor kidneys: Nature, incidence, and influence on graft function. Transpl Int 11: 22-27, 1998.
15. Lehtonen SR, Taskinen EI, Isoniemi HM: Histopathological findings in renal allografts at time of transplantation and correlation with onset of graft function. APMIS 107: 945-950, 1999.
16. Oda A, Morozumi K, Uchida K:Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts. Clin Transplant 13[Suppl 1]: 6-12, 1999.
17. Oberbauer R, Rohrmoser M, Regele H, Mühlbacher F, Mayer G: Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10: 2006-2013, 1999.
18. Kuypers DR, Chapman JR, O'Connell PJ, Allen RD, Nankivell BJ: Predictors of renal transplant histology at three months. Transplantation 67: 1222-1230, 1999.
19. Lu AD, Desai D, Myers BD, Dafoe DC, Alfrey EJ: Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation. Am J Surg 180: 470-474, 2000.
20. Randhawa PS, Minervini MI, Lombardero M, Duquesnoy R, Fung J, Shapiro R, Jordan M, Vivas C, Scantlebury V, Demetris A: Biopsy of marginal donor kidneys: Correlation of histologic findings with graft dysfunction. Transplantation 69: 1352-1357, 2000.
21. Di Paolo S, Stallone G, Schena A, Infante B, Gesualdo L, Paolo Schena F: Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions. Transplantation 73: 623-627, 2002.
22. Escofet X, Osman H, Griffiths DF, Woydag S, Adam Jurewicz W: The presence of glomerular sclerosis at time zero has a significant impact on function after cadaveric renal transplantation. Transplantation 75: 344-346, 2003.
23. Howie AJ, Ferreira MA, Lipkin GW, Adu D: Measurement of chronic damage in the donor kidney and graft survival. Transplantation 77: 1058-1065, 2004.
24. Ortiz F, Paavonen T, Törnroth T, Koskinen P, Finne P, Salmela K, Kyllönen L, Grönhagen-Riska C, Honkanen E: Predictors of renal allograft histologic damage progression. J Am Soc Nephrol 16: 817-824, 2005.
25. Lopes JA, Moreso F, Riera L, Carrera M, Ibernon M, Fulladosa X, Grinyó JM, Serón D: Evaluation of pre-implantation kidney biopsies: Comparison of Banff criteria to a morphometric approach. Kidney Int 67: 1595-1600, 2005.
26. Ugarte R, Kraus E, Montgomery RA, Burdick JF, Ratner L, Haas M, Hawxby AM, Karp SJ: Excellent outcomes after transplantation of deceased donor kidneys with high terminal creatinine and mild pathologic lesions. Transplantation 80: 794-800, 2005.
27. Re L, Cicora F, Petroni J, Goldberg J, Rial MC, Casadei D: Comparison between clinical and histopathological scoring in cadaveric kidney transplantation and its correlation with posttransplant evolution. Transplant Proc 38: 903-904, 2006.
28. Arias LF, Blanco J, Sanchez-Fructuoso A, Prats D, Duque E, Sáiz- Pardo M, Ruiz J, Barrientos A: Histologic assessment of donor kidneys and graft outcome: Multivariate analyses. Transplant Proc 39: 1368-1370, 2007.
29. Ibernon M, González-Segura C, Moreso F, Gomà M, Serón D, Fulladosa X, Torras J, Garcia-Huete L, Gil-Vernet S, Cruzado JM, Carrera M, Duarte V, Grinyó JM: Donor structural and functional parameters are independent predictors of renal function at 3 months. Transplant Proc 39: 2095-2098, 2007.
30. Kayler LK, Mohanka R, Basu A, Shapiro R, Randhawa PS: Correlation of histologic findings on preimplant biopsy with kidney graft survival. Transpl Int 21: 892-898, 2008.
31. Carroll RP, Macgregor L, Walker RG: The improvement in survival of expanded criteria donor kidneyswith transplantation era. Clin Transplant 22: 324-332, 2008.
32. Munivenkatappa RB, Schweitzer EJ, Papadimitriou JC, Drachenberg CB, Thom KA, Perencevich EN, Haririan A, Rasetto F, Cooper M, Campos L, Barth RN, Bartlett ST, Philosophe B: The Maryland aggregate pathology index: A deceased donor kidney biopsy scoring system for predicting graft failure. AmJ Transplant 8: 2316-2324, 2008.
33. Anglicheau D, Loupy A, Lefaucheur C, Pessione F, Létourneau I, Côté I, Gaha K, Noël LH, Patey N, Droz D, Martinez F, Zuber J, Glotz D, Thervet E, Legendre C: A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant 8: 2325-2334, 2008.
34. Matignon M, Desvaux D, Noël LH, Roudot-Thoraval F, Thervet E, Audard V, Dahan K, Lang P, Grimbert P: Arteriolar hyalinization predicts delayed graft function in deceased donor renal transplantation. Transplantation 86: 1002-1005, 2008.
35. Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, Oberbauer R, Schwarz C, Mitterbauer C, Kainz A, Karkoszka H, Wiecek A, Mayer B, Mayer G: Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell 7: 491-497, 2008.
36. Wazna E, Pazik J, Perkowska-Ptasińska A, Lewandowski Z, Nazarewski S, Chmura A, Durlik M: Arteriolar hyalinization in implantation kidney biopsies as a predictor of graft function. Transplant Proc 41: 2975-2977, 2009.
37. Cockfield SM, Moore RB, Todd G, Solez K, Gourishankar S: The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation. Transplantation 89: 559-566, 2010.
38. Sulikowski T, Tejchman K, Zietek Z, Urasińska E, Domański L, Sieńko J, Romanowski M, Safranow K, Zukowski M, Ciechanowicz A, Ciechanowski K, Ostrowski M: Histopathologic evaluation of pretransplantation biopsy as a factor influencing graft function after kidney transplantation in 3-year observation. Transplant Proc 42: 3375-3381, 2010.
39. Lin NC, Yang AH, King KL, Wu TH, Yang WC, Loong CC: Results of kidney transplantation from high-terminal creatinine donors and the role of time-zero biopsy. Transplant Proc 42: 3382-3386, 2010.
40. Navarro MD, López-Andréu M, Rodríguez-Benot A, Ortega-Salas R, Morales ML, López-Rubio F, García PA: Significance of preimplantation analysis of kidney biopsies from expanded criteria donors in long-term outcome. Transplantation 91: 432-439, 2011.
41. Pokorná E, Vítko S, Chadimová M, Schück O, Ekberg H: Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 69: 36-43, 2000.
42. Edwards EB, Posner MP, Maluf DG, Kauffman HM: Reasons for non-use of recovered kidneys: The effect of donor glomerulosclerosis and creatinine clearance on graft survival. Transplantation 77: 1411-1415, 2004.
43. Cicciarelli J, Cho Y, Mateo R, El-Shahawy M, Iwaki Y, Selby R: Renal biopsy donor group: The influence of glomerulosclerosis on transplant outcomes. Transplant Proc 37: 712-713, 2005.
44. Bajwa M, Cho YW, Pham PT, Shah T, Danovitch G, Wilkinson A, Bunnapradist S: Donor biopsy and kidney transplant outcomes: An analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation 84: 1399-1405, 2007.
45. Sung RS, Christensen LL, Leichtman AB, Greenstein SM, Distant DA, Wynn JJ, Stegall MD, Delmonico FL, Port FK: Determinants of discard of expanded criteria donor kidneys: Impact of biopsy and machine perfusion. Am J Transplant 8: 783-792, 2008.
46. Haas M, Segev DL, Racusen LC, Bagnasco SM, Melancon JK, Tan M, Kraus ES, Rabb H, Ugarte RM, Burdick JF, Montgomery RA: Arteriosclerosis in kidneys from healthy live donors: Comparison of wedge and needle core perioperative biopsies. Arch Pathol Lab Med 132: 37-42, 2008.
47. Mazzucco G, Magnani C, Fortunato M, Todesco A, Monga G: The reliability of pre-transplant donor renal biopsies (PTDB) in predicting the kidney state. A comparative single-centre study on 154 untransplanted kidneys. Nephrol Dial Transplant 25: 3401-3408, 2010